Licochalcone B
Licochalcone B (LCB) exhibits antitumor activity against bladder cancer cell lines in vitro and in vivo, while both LCB and Licochalcone D (LCD) demonstrate anti-inflammatory effects by suppressing LPS-induced mediators. A novel LCB derivative further shows protective effects against endotoxin shock in mice, highlighting its potential in oncology and immunology research.
Product Specifications
CAS Number
58749-23-8
Product Name Alternative
Beta Amyloid, BetaAmyloid, Abeta, b Amyloid, bAmyloid, Apoptosis, Amyloid-β, Inhibitor, Licochalcone B, inhibit, NOD-like Receptor (NLR), β-amyloid peptide, β Amyloid, βAmyloid
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience
Purity
99.33% (May vary between batches)
Solubility
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.:Soluble;10% DMSO+90% Saline:1 mg/mL (3.49 mM) ; DMSO:150 mg/mL (523.96 mM)
Smiles
COc1c (O) c (O) ccc1\C=C\C (=O) c1ccc (O) cc1
Molecular Formula
C16H14O5
Molecular Weight
286.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
